Bristol Myers Squibb (BMY) Q3 2023 Earnings Call Transcript

BMY earnings call for the period ending September 30, 2023.

Related Keywords

Sweden , United States , France , Norway , Canada , Robyn Karnauskas Truist , Chris Shibutani , Terence Flynn Morgan Stanley , Seamus Fernandez Guggenheim , Bristol Myers Squibb , Evan Seigerman , David Elkins , Adam Lenkowsky , Carter Gould Barclays , Raymond James , Samit Hirawat , Olivia Brayer , Chris Schott Jpmorgan , Giovanni Caforio , David Risinger , Tim Anderson , Luisa Hector , Andrew Baum Citi , Dane Leone , Chris Schott , Robyn Karnauskas , Luisa Hector Berenberg , Carter Gould , Andrew Baum , Seamus Fernandez , Terence Flynn , Mohit Bansal , Chris Boerner , Steven Scala , David Risinger Leerink , Chris Shibutani Goldman Sachs , America Merrill Lynch , Olivia Brayer Cantor Fitzgerald , Geoff Meacham , Cantor Fitzgerald , Company Analyst , Wolfe Research , Geoff Meacham Bank , Tim Anderson Wolfe Research Analyst , Morgan Stanley , Wells Fargo , Head Of Global Drug Development , Barclays , Goldman Sachs , Stim Power , Bristol Myers , Motley Fool Stock Advisor , Stock Advisor , Chief Executive , Operating Officer , Fast Track Designation , Chief Operating Officer , Capital Markets , Medical Officer , Global Drug , Fargo Securities , Chief Commercialization , Berenberg Capital Markets , Guggenheim Partners , Chief Medical Officer , Leerink Partners ,